Page 1 of Clinical Trials for Drug Fenofibrate Simvastatin, 16 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
Last Updated: July 7, 2009
Condition(s): Hyperlipidemia
2
Completed
Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin
Last Updated: July 7, 2009
Condition(s): Hyperlipidemia
3
Completed
Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin
Last Updated: July 7, 2009
Condition(s): Hyperlipidemia
4
Completed
Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
Last Updated: July 7, 2009
Condition(s): Cardiovascular Diseases
5
Active, not recruiting
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Last Updated: December 4, 2009
Condition(s): Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia; Hypertension; Diabetes Mellitus, Type 2; Diabetes Mellitus; Coronary Disease
6
Completed
Effectiveness of Two Approved Drugs in Lowering High Cholesterol
Last Updated: January 21, 2010
Condition(s): Hypercholesterolemia
7
Completed
Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents
Last Updated: December 14, 2009
Condition(s): Healthy
8
Completed
Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.
Last Updated: June 3, 2009
Condition(s): Dyslipidemia; Coronary Heart Disease; Mixed Dyslipidemia
9
Completed
Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study
Last Updated: August 20, 2008
Condition(s): Type II Diabetes Mellitus; Mixed Dyslipidemia
10
Completed
Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome
Last Updated: November 7, 2011
Condition(s): Dyslipidemia
11
Completed
A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia
Last Updated: January 21, 2010
Condition(s): Hyperlipidemia; Hypercholesterolemia; Hypertriglyceridemia
12
Active, not recruiting
The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines
Last Updated: May 3, 2011
Condition(s): Diabetes; Dyslipidemia; Inflammation; Cytokines
13
Completed
Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.
Last Updated: May 23, 2012
Condition(s): Type 2 Diabetes
14
Recruiting
A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Last Updated: March 16, 2012
Condition(s): Cardiovascular Diseases
15
Completed
Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)
Last Updated: July 21, 2011
Condition(s): Hypertriglyceridemia
16
Active, not recruiting
Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL
Last Updated: December 13, 2011
Condition(s): Hypertriglyceridemia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Fenofibrate+Simvastatin

Page 1 of Clinical Trials for Drug Fenofibrate Simvastatin, 16 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About